ClinicalTrials.govpublic full text
STEPwise De-escalation and Optimizing Withdrawal of ARNI and SGLT2i in Normalized Heart Failure
heart failure with reduced ejection fraction, heart failure, ventricular dysfunction, left, hfimpef, arni, sacubitril/valsartan, sglt2 inhibitor, guideline-directed medical therapy, reverse remodeling, valvular heart disease, ischemic cardiomyopathy, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 898186
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.